Literature DB >> 8521451

Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteines.

S M Kipriyanov1, S Dübel, F Breitling, R E Kontermann, S Heymann, M Little.   

Abstract

Two antibody single-chain Fv (scFv) fragments carrying five C-terminal histidine residues were expressed in Escherichia coli as periplasmic inclusion bodies. Their variable heavy (VH) and light (VL) domains are derived from the mouse monoclonal antibody 215 (MAb215), specific for the largest subunit of RNA polymerase II of Drosophila melanogaster and rat MAb Yol1/34, specific for pig brain alpha-tubulin. ScFv-215 contains an additional cysteine residue near to its C-terminus. After solubilization of inclusion bodies followed by immobilized metal affinity chromatography (IMAC) in 6M urea and a renaturation procedure, scFv monomers, noncovalent dimers, and aggregated antibody fragments were separated by size exclusion chromatography. In addition, a fraction of disulfide-bonded scFv-215 homodimers (scFv')2 was also isolated. The various antibody forms appear to be in equilibrium after renaturation since first peak composed mainly of aggregates could be resolved into a similar pattern of aggregates, dimers, and monomers after repeating the denaturation/renaturation procedure. All fractions of the recombinant scFv-215 demonstrated high antigen-binding activity and specificity as shown by enzyme-linked immunosorbent assay (ELISA) and Western blot analysis. Affinity measurements carried out by competitive immunoassays showed that covalently linked (scFv')2 have binding constants quite close to those of the parental MAbs and fourfold higher than scFv' monomers. ScFv derivatives, specifically biotinylated through the free sulfhydryl group, recognize the corresponding antigen in ELISA and Western blot analysis, thus demonstrating the possibility of using chemically modified scFv antibodies for immunodetection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521451     DOI: 10.1007/BF02791580

Source DB:  PubMed          Journal:  Cell Biophys        ISSN: 0163-4992


  40 in total

1.  The disulfide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in Escherichia coli.

Authors:  R Glockshuber; T Schmidt; A Plückthun
Journal:  Biochemistry       Date:  1992-02-11       Impact factor: 3.162

2.  Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.

Authors:  T Yokota; D E Milenic; M Whitlow; J Schlom
Journal:  Cancer Res       Date:  1992-06-15       Impact factor: 12.701

3.  A comparison of strategies to stabilize immunoglobulin Fv-fragments.

Authors:  R Glockshuber; M Malia; I Pfitzinger; A Plückthun
Journal:  Biochemistry       Date:  1990-02-13       Impact factor: 3.162

4.  Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

Authors:  J S Huston; D Levinson; M Mudgett-Hunter; M S Tai; J Novotný; M N Margolies; R J Ridge; R E Bruccoleri; E Haber; R Crea
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  A bacterially expressed single-chain Fv construct from the 2B4 T-cell receptor.

Authors:  I Kurucz; C R Jost; A J George; S M Andrew; D M Segal
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

6.  Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli.

Authors:  P Pack; A Plückthun
Journal:  Biochemistry       Date:  1992-02-18       Impact factor: 3.162

7.  Spontaneous assembly of bivalent single chain antibody fragments in Escherichia coli.

Authors:  D P McGregor; P E Molloy; C Cunningham; W J Harris
Journal:  Mol Immunol       Date:  1994-02       Impact factor: 4.407

8.  Engineering Fab' fragments for efficient F(ab)2 formation in Escherichia coli and for improved in vivo stability.

Authors:  M L Rodrigues; B Snedecor; C Chen; W L Wong; S Garg; G S Blank; D Maneval; P Carter
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

9.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

10.  A recombinant immunotoxin that is active on prostate cancer cells and that is composed of the Fv region of monoclonal antibody PR1 and a truncated form of Pseudomonas exotoxin.

Authors:  U Brinkmann; M Gallo; E Brinkmann; S Kunwar; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 12.779

View more
  4 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

2.  Molecular immunolabeling with recombinant single-chain variable fragment (scFv) antibodies designed with metal-binding domains.

Authors:  Marek Malecki; Annie Hsu; Lynn Truong; Sylvia Sanchez
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

3.  Procaryotic expression of single-chain variable-fragment (scFv) antibodies: secretion in L-form cells of Proteus mirabilis leads to active product and overcomes the limitations of periplasmic expression in Escherichia coli.

Authors:  J F Rippmann; M Klein; C Hoischen; B Brocks; W J Rettig; J Gumpert; K Pfizenmaier; R Mattes; D Moosmayer
Journal:  Appl Environ Microbiol       Date:  1998-12       Impact factor: 4.792

4.  Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications.

Authors:  Tove Olafsen; Chia-Wei Cheung; Paul J Yazaki; Lin Li; Gobalakrishnan Sundaresan; Sanjiv S Gambhir; Mark A Sherman; Lawrence E Williams; John E Shively; Andrew A Raubitschek; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2004-01       Impact factor: 1.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.